Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Safety and Efficacy of Transcatheter Administration of Tissue Plasminogen Activating Factor as Adjuvant Therapy for Intraventricular Hemorrhage.

Krel M, Brazdzionis J, Podkovik S, Miulli DE, Wacker MR, Beamer Y.

Cureus. 2019 Sep 27;11(9):e5785. doi: 10.7759/cureus.5785.

2.

Safety of the transventricular approach to deep brain stimulation: A retrospective review.

Ray K, Krel M, Bernstein J, Kashyap S, Ananda A.

Surg Neurol Int. 2019 Oct 4;10:192. doi: 10.25259/SNI_244_2019. eCollection 2019.

3.

Tight Control of Systolic Blood Pressure in Spontaneous Intraparenchymal Brain Hemorrhage.

Krel M, Brazdzionis J, Wiginton JG 4th, Miulli DE, Wacker MR, Cortez V.

Cureus. 2019 Jul 23;11(7):e5215. doi: 10.7759/cureus.5215.

4.

Minimization of Intraparenchymal Hemorrhagic Stroke Size by Optimization of Serum Lipids.

Krel M, Miulli DE, Jung H, Wiginton JG 4th, Brazdzionis J, Wacker MR, Hoshek S, Menoni R.

Cureus. 2019 Apr 8;11(4):e4406. doi: 10.7759/cureus.4406.

5.

Host biomarkers of invasive pulmonary aspergillosis to monitor therapeutic response.

Krel M, Petraitis V, Petraitiene R, Jain MR, Zhao Y, Li H, Walsh TJ, Perlin DS.

Antimicrob Agents Chemother. 2014 Jun;58(6):3373-8. doi: 10.1128/AAC.02482-14. Epub 2014 Mar 31.

Supplemental Content

Support Center